Close Menu

NEW YORK – OncoCyte said after the close of the market on Tuesday that its third quarter net loss rose 73 percent year over year as it prepares for 2020 launches of two lung cancer tests.

Next year, the firm plans to release a test to noninvasively assess risk in patients with lung nodules and another to predict which patients may need added chemotherapy after surgery.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Forensic genetic firm Verogen has bought the genetic genealogy site GEDmatch.

Researchers have 3D-printed plastic bunnies that encase the information needed to make more such bunnies in DNA, according to Discover magazine.

Dan Rather, the former CBS Evening News anchor and executive producer of a new documentary, writes at the Guardian that everyone needs to know about CRISPR.

In PNAS this week: analysis of FOXA1 upregulation in ER-positive breast cancer, gene editing to correct recessive dystrophic epidermolysis bullosa, and more.